Seipel Kenneth Duane

Interim CEO Kenneth Duane Seipel buys 25,000 shares of CTRN at $14.39 amid stock down 55.5% from 52-week high; prior CTRN purchases all underwater.

Kenneth Duane Seipel, Interim CEO, purchased 25,000 shares at $14.39 on 2024-08-28, increasing his holdings to 282.1K shares. The transaction occurs as CTRN trades at $14.30 current price, down -55.5% from the 52-week high of $32.13 and -27.1% over the prior 30 days. Notably, Seipel's three prior purchases at CTRN (on 2024-07-10, 07-11, and 07-12) all show negative 30-day returns ranging from -14.2% to -14.6%, and none of those outcomes are yet measurable at the 90-day mark. The company's fundamentals are weak: it posted a net loss of $-3.4M in the latest quarter, annual revenue declined -5.9% year-over-year, and the firm was unprofitable over its most recent full fiscal year. The pattern of repeated purchases at declining prices, combined with deteriorating company profitability and stock momentum, suggests the insider's buying has not been successful at catching support levels or reversals.

Interim CEO Kenneth Duane Seipel purchased 282,644 shares for $5,377,822.26 across 3 transactions (Jul 10-12); stake expanded 765.6%.

Kenneth Duane Seipel, Interim CEO, executed 3 separate purchases totaling 282,644 shares for $5,377,822.26 between July 10-12, 2024, at a blended average price of $19.03, increasing his holdings from 36,918 shares to 319,562 shares. This represents a 765.6% expansion of his stake at prices 42.0% above the current price of $18.65, shortly after the stock declined 15.4% in the prior 30 days. The purchase occurs against a backdrop of deteriorating fundamentals—the company posted $-3,426,000.00 net income (unprofitable over the full fiscal year), negative annual revenue growth of -5.9%, and a market cap of $160,302,289.05—making this a substantial capital commitment by the interim CEO at a time when operational performance is challenged.